Ellis; Jonathan Henry
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ellis; Jonathan Henry.The latest application filed is for "humanized anti-il-18 antibodies".
Company Profile
4.25.52
- Ellis; Jonathan Henry - Stevenage GB
- - Stevenage GB
- Ellis; Jonathan Henry - King of Prussia PA
- Ellis; Jonathan Henry - Hertfordshire GB
- ELLIS; JONATHAN HENRY - STEVENAGE HERTFORDSHIRE GB
- Ellis; Jonathan Henry - Ware GB
Patent Activity
| Patent | Date |
|---|---|
| Method of treatment with humanized anti-IL-18 antibodies Grant 10,703,814 - Ellis , et al. | 2020-07-07 |
| Humanized Anti-il-18 Antibodies App 20190031753 - ELLIS; Jonathan Henry ; et al. | 2019-01-31 |
| Immunoglobulins App 20170029497 - ELLIS; Jonathan Henry ; et al. | 2017-02-02 |
| Humanized anti-IL-18 antibodies Grant 9,499,617 - Ellis , et al. November 22, 2 | 2016-11-22 |
| Antigen-binding Constructs App 20160207993 - ASHMAN; Claire ; et al. | 2016-07-21 |
| Antibodies Against Amyloid-beta Peptide App 20160024197 - BURBIDGE; Stephen Anthony ; et al. | 2016-01-28 |
| Antibodies Grant 9,193,784 - Burbidge , et al. November 24, 2 | 2015-11-24 |
| Humanized anti-beta-amyloid antibodies Grant 08921523 - | 2014-12-30 |
| Humanized anti-beta-amyloid antibodies Grant 8,921,523 - Alard , et al. December 30, 2 | 2014-12-30 |
| Antigen binding proteins Grant 8,858,943 - Burbidge , et al. October 14, 2 | 2014-10-14 |
| NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological Diseases App 20140147435 - ELLIS; Jonathan Henry ; et al. | 2014-05-29 |
| Humanized Anti-il-18 Antibodies App 20140105894 - ELLIS; Jonathan Henry ; et al. | 2014-04-17 |
| IL-13 binding protein Grant 8,680,245 - Ashman , et al. March 25, 2 | 2014-03-25 |
| Antibodies App 20140050719 - Burbidge; Stephen Anthony ; et al. | 2014-02-20 |
| Humanized anti-IL-18 antibodies Grant 8,637,018 - Ellis , et al. January 28, 2 | 2014-01-28 |
| Immunoglobulins App 20130287781 - CLEGG; Stephanie Jane ; et al. | 2013-10-31 |
| Antigen-binding Proteins With Increased Fcrn Binding App 20130243764 - Ellis; Jonathan Henry ; et al. | 2013-09-19 |
| Immunoglobulins Grant 8,362,208 - Clegg , et al. January 29, 2 | 2013-01-29 |
| Novel Uses App 20120315267 - Clegg; Stephanie Jane ; et al. | 2012-12-13 |
| Antibodies against amyloid-.beta. peptide Grant 8,227,576 - Burbidge , et al. July 24, 2 | 2012-07-24 |
| Immunoglobulins App 20120100137 - Ellis; Jonathan Henry ; et al. | 2012-04-26 |
| Il-13 Binding Protein App 20120082682 - Ashman; Claire ; et al. | 2012-04-05 |
| Antigen-binding Proteins App 20120070436 - Easeman; Richard Lewis ; et al. | 2012-03-22 |
| Humanised anti-interleukin-18 antibody Grant 8,133,978 - Ellis , et al. March 13, 2 | 2012-03-13 |
| Humanised anti-MAG antibody or functional fragment thereof Grant 8,071,731 - Ellis , et al. December 6, 2 | 2011-12-06 |
| Novel Antibodies App 20110262430 - Ellis; Jonathan Henry ; et al. | 2011-10-27 |
| Myostatin Binding Proteins App 20110256132 - Ashman; Claire ; et al. | 2011-10-20 |
| Chimeric And Humanised Monoclonal Antibodies Against Interleukin-13 App 20110243928 - ASHMAN; CLAIRE ; et al. | 2011-10-06 |
| Immunoglobulins App 20110245470 - ELLIS; Jonathan Henry ; et al. | 2011-10-06 |
| Il-23 Antibodies App 20110206686 - Bembridge; Gary Peter ; et al. | 2011-08-25 |
| NOGO-a neutralising immunoglobulin for treatment of neurological diseases Grant 7,988,964 - Ellis , et al. August 2, 2 | 2011-08-02 |
| Antibodies Against Amyloid-Beta Peptide App 20110142824 - Burbidge; Stephan Anthony ; et al. | 2011-06-16 |
| Antigen Binding Proteins App 20110064740 - Burbidge; Stephen Anthony ; et al. | 2011-03-17 |
| NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological Diseases App 20110054149 - ELLIS; JONATHAN HENRY ; et al. | 2011-03-03 |
| Antigen Binding Proteins App 20110014182 - Alard; Philippe Marc Louis ; et al. | 2011-01-20 |
| Antigen-binding Constructs App 20110008345 - Ashman; Claire ; et al. | 2011-01-13 |
| Immunoglobulins Grant 7,858,753 - Ellis , et al. December 28, 2 | 2010-12-28 |
| Immunoglobulins App 20100303821 - ASHMAN; CLAIRE ; et al. | 2010-12-02 |
| Chimeric and humanised monoclonal antibodies against Interleukin-13 Grant 7,807,788 - Ashman , et al. October 5, 2 | 2010-10-05 |
| Immunoglobulins App 20100221260 - Clegg; Stephanie Jane ; et al. | 2010-09-02 |
| Immunoglobulins which bind NOGO Grant 7,780,964 - Ellis , et al. August 24, 2 | 2010-08-24 |
| Novel Antibodies Against Igf-ir App 20100047243 - Burden; Michael Neil ; et al. | 2010-02-25 |
| Humanised anti-mag antibody or functional fragment thereof Grant 7,612,183 - Ellis , et al. November 3, 2 | 2009-11-03 |
| Antigen Binding Proteins App 20090162358 - Alard; Philippe Marc Louis ; et al. | 2009-06-25 |
| Antigen-binding Constructs App 20090148905 - ASHMAN; Claire ; et al. | 2009-06-11 |
| Dna Expression Vectors App 20090130126 - CATCHPOLE; Ian Richard ; et al. | 2009-05-21 |
| Immunoglobulins App 20090123479 - Bembridge; Gary Peter ; et al. | 2009-05-14 |
| Humanised Anti-MAG Antibody or Functional Fragment Thereof App 20090053214 - Ellis; Jonathan Henry ; et al. | 2009-02-26 |
| Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins Grant 7,351,818 - Coste , et al. April 1, 2 | 2008-04-01 |
| Immunoglobulins App 20070292432 - ELLIS; Jonathan Henry ; et al. | 2007-12-20 |
| Immunoglobulins App 20070286861 - Ellis; Jonathan Henry ; et al. | 2007-12-13 |
| Nucleic Acid Vaccination App 20070269451 - Crowe; James Scott ; et al. | 2007-11-22 |
| Chimeric and Humanised Monoclonal Antibodies Against Interleukin-13 App 20070258979 - Ashman; Claire ; et al. | 2007-11-08 |
| Nogo-a neutralising immunoglobulins for treatment of neurological diseases App 20070065430 - Ellis; Jonathan Henry ; et al. | 2007-03-22 |
| Vaccines App 20060251665 - Burden; Michael Neil ; et al. | 2006-11-09 |
| Antibodies App 20060165681 - Ellis; Jonathan Henry ; et al. | 2006-07-27 |
| Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use App 20060147417 - Ashman; Claire ; et al. | 2006-07-06 |
| Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins Grant 7,034,142 - Coste , et al. April 25, 2 | 2006-04-25 |
| Antibodies to CD23, derivatives thereof, and their therapeutic uses Grant 7,008,623 - Bonnefoy , et al. March 7, 2 | 2006-03-07 |
| Immunoglobulins App 20060029603 - Ellis; Jonathan Henry ; et al. | 2006-02-09 |
| Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins App 20050266488 - Coste, Herve Jean-Clement ; et al. | 2005-12-01 |
| Vaccine App 20050260216 - Ashman, Claire ; et al. | 2005-11-24 |
| Vaccine App 20050186209 - Ashman, Claire ; et al. | 2005-08-25 |
| Humanized antibodies to CD38 App 20050158305 - Ellis, Jonathan Henry ; et al. | 2005-07-21 |
| Method Of Determining Whether A Patient Afflicted With Cancer Can Be Treated By A Therapeutic Agent That Targets The 17-1a Antigen App 20050032133 - BARRATT, PAULA LOUISE ; et al. | 2005-02-10 |
| Dna expression vectors App 20040082531 - Catchpole, Ian Richard ; et al. | 2004-04-29 |
| Vaccine App 20030194391 - Ashman, Claire ; et al. | 2003-10-16 |
| Nucleic acid vaccination App 20030133909 - Crowe, James Scott ; et al. | 2003-07-17 |
| Humanized antibodies to CD38 App 20020164788 - Ellis, Jonathan Henry ; et al. | 2002-11-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 